Z-0937-2021 Class II Terminated

Recalled by Qiagen Sciences LLC — Germantown, MD

Recall Details

Product Type
Devices
Report Date
February 3, 2021
Initiation Date
December 11, 2020
Termination Date
April 22, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
575 kits US

Product Description

therascreen PIK3CA RGQ PCR Kit (23) US IVD product- aid clinicians in identifying breast cancer patients who may be eligible for treatment with PIQRAY (alpelisib) based on a PIK3CA Mutation Detected result. REF 873121

Reason for Recall

Kit may generate false Q546R mutation positive results caused by nonspecific molecular interactions within the Q546R higher than previously observed and described within the Instructions For Use.

Distribution Pattern

CA, IN, MI, MN, NC, NJ, NM, OH, TX

Code Information

All lots